Gene editing is a game-changer, creating substantial opportunities for some of the leading gene editing stocks. More
Articles
MU Stock Earnings: Micron Technology Beats EPS, Beats Revenue for Q3 2024
MU stock results show that Micron Technology beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024. More
MLKN Stock Earnings: MillerKnoll Beats EPS, Misses Revenue for Q4 2024
MLKN stock results show that MillerKnoll beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2024. More
FUL Stock Earnings: H.B. Fuller Beats EPS, Beats Revenue for Q2 2024
FUL stock results show that H.B. Fuller beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
FC Stock Earnings: Franklin Covey Beats EPS, Beats Revenue for Q3 2024
FC stock results show that Franklin Covey beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024. More
CNXC Stock Earnings: Concentrix Beats EPS, Beats Revenue for Q2 2024
CNXC stock results show that Concentrix beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
WS Stock Earnings: Worthington Steel Beats EPS, Beats Revenue for Q4 2024
WS stock results show that Worthington Steel beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024. More
